EHA 2017: Newly Diagnosed Myeloma
Today many newly diagnosed myeloma patients will receive induction therapy and then go to stem cell transplant. At the European…
Generic Drugs for Multiple Myeloma: Biosimilars
Over the years we have become familiar with generic drugs, approved by FDA, and treated as “the same” as their…
Full Show: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg
Dirk Hose, MD Anja Seckinger, MD Interview Date: May 24, 2017 Summary Many myeloma patients are familiar with monoclonal antibodies,…
Full Show: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg
Dirk Hose, MD Anja Seckinger, MD Interview Date: May 24, 2017 Summary Many myeloma patients are familiar with monoclonal antibodies,…
Our Next Show: Targeting BCMA and T Cells in New Bi-Specific Myeloma Antibody with Anja Seckinger, MD and Dirk Hose, MD, University of Heidelberg, Wednesday, May 24 @ 10 am Central
Wednesday, May 24, 2017 @ 8 am Pacific, 9 am Mountain, 10 am Central, 11 am Eastern Call In by…
Clinical Trial: Drug that Stops Myeloma Progression with Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
TGF-β, a multifunctional cytokine, is produced in multiple myeloma cells and cells in the bone marrow environment and stimulates myeloma…
UPCOMING MYELOMA CROWD ROUNDTABLES
August 19, 2017, Myeloma Crowd Round Tables: Jackson, Mississippi
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
September 23, 2017, Myeloma Crowd Round Tables: Detroit, Michigan
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
MYELOMA CROWD RESEARCH CAMPAIGNS
Myeloma Crowd Research Initiative (MCRI) Funds Two Immunotherapy Projects
The Myeloma Crowd Initiative selected two proposals it has selected for the MCRI crowdsourcing and…
Continuing the Fight for a Myeloma Cure: Dr. Tricot and Dr. Zhan’s Research to Improve Outcomes for High-Risk Myeloma Patients
Guido Tricot, MD, PhD has devotedly attended to thousands of multiple myeloma patients for over…
Thanks to our site sponsors:
